Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > I've had a nice...
View:
Post by mercedesman on Nov 02, 2021 11:06am

I've had a nice...

...run on my Crypto's of late...

...so I'm putting some of the profits into some undervalued stocks...

...EDT seems like a good bet with it being 35% off the financing price, and 50% off the price it was trading at,  in the days leading up to the latest bought deal financing by AGP...all with quite heavy insider participation.

A few good things have happened since we last traded at these levels in 2018 and 2017

For example I believe that the last time we traded at these levels ... was well before:
  • Baxter distribution contract (derisking of Tigris, and cost covering)
  • Kellum hired as CMO
  • "Confirmatory" Phase 3b, 2:1, baysian, open label Trial
  • SAMI FDA & HC approvals
  • Golden Hour seminal article by Ronco (advocating for EAA and PMX-HP)
  • World Sepsis Alliance talk & keynote acknowledgement of Spectral at Vincenza
  • US presidential push towards Home Dialysis
  • Outset and NxStage valuations of > $ 2B for their HD pumps
  • Possibe benefit of PMX in treatment of Covid recently acknowledged by Kellum
  • Lots more RWE for PMX-HP
  • some dosing rationale on why the Euphrates results could have been better even outside the new target sub-group (filter capcity, duration, # filters, etc.)
  • a demonstrated appetite for blood filtration devices in the US (se AEMD and CTSO) - even ones far less advanced (in terms of FDA approval) than Spectral.
 Nothing else negative has happened that I can determine, other than a continuation of the silence.


MM
Comment by GoldMemberT on Nov 02, 2021 12:15pm
nothing bad? they pulled a fast one for a financing and haven't had a significant non fluff piece of news since. That in and of itself is just akin spitting in investors faces. they haven't spun out dialco as promised they don't have a partner that they claimed they would have for Dialco. no news on continued "heightened enrolment" no start of dimi trial Did ...more  
Comment by oilandgasman on Nov 02, 2021 12:27pm
Amen ..Shitshow, it makes me sick given the words i've been told.
Comment by mercedesman on Nov 02, 2021 12:59pm
I'll admit. Should have phrased that better. I should have said.... What negative event has befallen the Company that reduces it's LT potential?  Is their lack of promotion, and or execution delays a negative event that will alter the final outcome of the game?  I doubt it...as annoying as it is. 100 % agree regarding what you have pointed out and the resultant lack of support ...more  
Comment by GoldMemberT on Nov 02, 2021 1:24pm
the facts are 100% stacked up against you. Seto must be embarrassed. I wouldn't leave my house after this performance. 
Comment by mercedesman on Nov 02, 2021 1:46pm
"the facts are 100% stacked up against you. Seto must be embarrassed. I wouldn't leave my house after this performance. " GMember Meaning...I guess... that you believe that the hiring of Seto has put this Company into a permanent tailspin that will result in the non-fullfillment of its FDA approval goals (and  the non-sale of it's assets/IP to the highest bidder? Do you ...more  
Comment by GoldMemberT on Nov 02, 2021 1:50pm
The FDA outcome is not guaranteed. Period.   
Comment by mercedesman on Nov 02, 2021 2:05pm
True.  But the outcome is no longer binary. I would argue that it is ternary or quaternary. And the odds of any one event occuring have been increasing despite the apparent mismanagement at the top. This investment is and always has been about the individual investors (1) assessment of the probablity of success, and (2)  level of patience. On the latter point.... "The stock ...more  
Comment by GoldMemberT on Nov 02, 2021 2:00pm
I think Seto, like his predecessors, is self serving. Had high hopes for him, thought there would make changes for the better including actively trying to improve their relationship and engagement with investors. What we got is a wet noodle.  The company has literally been on a tailspin since he got hired. No, really, it has been consistently going down since the moment he was put in charge ...more  
Comment by GoldMemberT on Nov 02, 2021 12:17pm
the price is down to 27cents and you're grasping at straws hoping someone who made money on crypto would put it here? Ha ha ha 
Comment by GoldMemberT on Nov 02, 2021 12:21pm
As a side note: I don't think your pumping is helping. Management didn't leave you with a lot to work with. We aren't even in the thick of tax loss selling season yet. Maybe hold on to your crypto and buy this when we find a bottom.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities